Baixar PDF

Outros usuários também visualizaram estes artigos

Patient-reported outcomes of treatment and adverse effects following acute lymphoblastic leukemia: a low- and middle-income country cross-sectional study Eduardo Cerello Chapchap; Nina Melo; Denise Martins; Maria Lucia Lee; Nelson Hamerschlak;
Hematol Transfus Cell Ther. 2024;46 Supl 6:S182-92
A comprehensive consolidation of data on the connection between CDKN2A polymorphisms and the susceptibility to childhood acute lymphoblastic leukemia Maryam Aghasipour; Fatemeh Asadian; Seyed Alireza Dastgheib; Abolhasan Alijanpour; Ali Masoudi; Maedeh Barahman; Mohammad Golshan-Tafti; Reza Bahrami; Amirmasoud Shiri; Hossein Aarafi; Kazem Aghili; Hossein Neamatzadeh;
Hematol Transfus Cell Ther. 2024;46 Supl 6:S332-45
Are delays in diagnosis and treatment of acute leukemia in a middle-income country associated with poor outcomes? A retrospective cohort study Yadith Karina Lopez-Garcia; Mayra Valdez-Carrizales; Jorge Adrián Nuñez-Zuno; Elia Apodaca-Chávez; Juan Rangel-Patiño; Roberta Demichelis-Gómez;
Hematol Transfus Cell Ther. 2024;46:366-73